Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer.
Rudin CM, Reck M, Johnson ML, Blackhall F, Hann CL, Yang JC, Bailis JM, Bebb G, Goldrick A, Umejiego J, Paz-Ares L.
Rudin CM, et al. Among authors: reck m.
J Hematol Oncol. 2023 Jun 24;16(1):66. doi: 10.1186/s13045-023-01464-y.
J Hematol Oncol. 2023.
PMID: 37355629
Free PMC article.
Review.